TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Anonymous $100 Million Gift Moves OHSU Within $82 Million Of Reaching $1 Billion Goal August 1, 2014
TCL Archive Cancer Policy: EMFs “Possible” Carcinogen, Panel Says; Plans Public Hearings August 7, 1998
